查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197528

醫學成像模型市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Medical Imaging Phantom Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，醫學影像模型市場預計將以 5.1% 的複合年增長率增長。

主要亮點

  • COVID-19 大流行對市場產生了影響。 大流行期間圖像量的減少影響了市場增長的速度。 例如，根據 2021 年加拿大放射技術專家協會的一份報告，COVID-19 疫情對全國醫學影像服務的等待時間產生了嚴重影響。 CT 掃描的等待時間為 50 至 82 天，MRI 掃描的平均等待時間為 89 天。 超過建議的 30 天等待時間 20 至 52 天。 由於 COVID-19，等待時間變得更長，影響了市場增長。 但是成像設備被用來觀察疾病對患者的長期影響。 圖像引導放射治療的最新進展有望改善患者及其家人 (IGRT) 的生活質量。 例如，2022 年 9 月，Qure.ai 與鹿特丹大學醫學中心合作推出了一個醫學成像實驗室。 最初計劃為三年，我們計劃使用胸部 CT、X 射線和腦部 CT 進行詳細的醫學影像診斷，以了解 COVID-19 的影響。 有了這樣的合作夥伴關係，預計醫學成像幻影市場將在預測期內增加。
  • 除了疾病負擔加重等因素外，意識的提高和產品的進步預計也會推動市場增長。 需要成像來監測和了解大腦區域並了解它們如何對不同刺激做出反應的疾病（例如神經系統疾病）的增加預計將促進市場增長。 例如，根據世界衛生組織 (WHO) 2022 年 9 月的報告，全球約有 5500 萬人患有癡呆症，每年報告的病例近 1000 萬例。 此外，根據同一數據，阿爾茨海默型癡呆最為常見，約佔所有癡呆患者的 60-70%。 同樣，根據世界衛生組織 2022 年 2 月的更新，癲癇影響了全球約 5000 萬人，使癲癇成為最常見的神經系統疾病之一，80% 的低度至中度癲癇患者生活在收入國家。 因此，神經系統疾病的高負擔預計會增加市場增長，因為它需要醫學影像為患者提供特定護理，並且研究市場有望增長。
  • 同樣，補貼為在藥物開發中使用幻影圖像提供基礎設施支持，這是市場增長的另一個驅動力。 例如，2022 年 3 月，Gold Standard Phantom 入選 2022 P4 精準醫療加速器計劃。 對於這個項目，公司投資了一個專用於體內 MRI 人體組織和器官成像的體模。 通過傳授無與倫比的專業知識、關鍵關係和新聯繫，這個由倫敦大學學院和 Capital Enterprises 協調的為期六個月的計劃將幫助精準醫學中小企業成長並採用它創造一個新的和獨特的環境。 因此，由於上述因素，如疾病負擔增加，以及意識和產品進步的提高，預計醫學成像幻影市場將在預測期內增長。 然而，該程序的高成本和缺乏訓練有素的專業人員預計會阻礙市場增長。

醫學影像幻影市場趨勢

在醫學影像模型市場，核醫學影像模型有望佔據主要市場份額

Nuclear Medicine Imaging Phantom是專門為醫學影像領域的掃描成像設計的系統，用於評估、分析和校準PET/CT等各種影像儀器的性能。 . 癌症患者增加等因素加上主要參與者的舉措預計將推動市場增長。 例如，根據 Cancer Facts & Figures 2022 的數據，2022 年美國將發生 190 萬新癌症病例和 609,360 例癌症死亡。 在全球範圍內，由於癌症流行，研究 PET 成像的使用正在增加。 許多學術研究正在研究核醫學成像在癌症中的應用。 例如，在 2021 年 4 月發表於國家醫學圖書館的一項研究中，FDG PET/CT 成像檢測了新診斷、未經治療的口腔鱗狀細胞癌 (SCC) 患者的頸部淋巴結轉移，發現其具有很高的陰性預測價值 因此，研究調查的增加有望通過提供對核醫學成像應用的洞察力來增加其在治療各種疾病中的採用，這有望促進市場增長。 因此，未來的市場增長將會增加。

此外，主要市場參與者的收購等舉措也有助於市場增長，因為收購有助於擴大產品領域和/或地區的主要參與者。 例如，2021 年 9 月，Million Technologies, Inc. 收購了 Computerized Image Reference Systems, Inc.，這是一家為醫療行業提供醫學成像和放射治療模型的供應商。 預計這些努力將增加產品在各個地區的可用性並促進市場的增長。 因此，上述因素有望推動醫學影像模型市場的發展。

預計北美將佔據很大的市場份額，預計在預測期內也會如此

由於該地區資金和產品引進的增加，預計北美將佔據醫學成像模型市場的很大份額。

該地區不斷增加的資金預計將在預測期內推動醫學成像的採用並促進市場增長。 例如，2021 年 7 月，加拿大聯邦政府和魁北克省將與聯邦基礎設施和社區部長以及衛生部長和社會服務分別投資於 209 個基礎設施項目，其中一部分為 1.883 億美元。 這筆資金使醫院能夠獲得先進的醫療技術。 因此，預測期內新醫院的建設預計將增加醫學成像的採用，增加該地區對醫學成像模型的需求。

此外，醫療機構的產品安裝是市場增長的另一個驅動力，因為它促進了該技術在該地區的廣泛採用。 例如，2022 年 11 月，Perimeter Medical Imaging AI Inc. 在德克薩斯州北部的一家醫院安裝了 Perimeter S 系列 OCT 系統。 Perime 是一家醫療技術公司，通過超高分辨率、實時、先進的成像工具推動癌症手術的轉型，以滿足未滿足的醫療需求。 因此，預計此類安裝將在預測期內推動市場增長。 因此，上述因素，如增加資金、產品引入等，有望促進醫學影像模型市場的增長。

醫學影像模型市場競爭對手分析

醫學成像模型市場競爭適中，由幾家大型企業組成，目前的市場壟斷者包括 Carville、Computerized Imaging Reference Systems, Inc、Pure Imaging Phantoms 和 Biodex。Medical System, Inc、Leeds Test Object Ltd、 Bartec Technologies Ltd、Gold Standard Phantoms、Kyoto Kagaku、Modus Medical Device Inc、PTW Freiburg GmbH。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 慢性病負擔加重
    • 產品演變
    • 提高對診斷成像的認識
  • 市場製約因素
    • 手術費用上漲
    • 缺乏訓練有素的專業人員
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品類型
    • X射線體模
    • 超聲波幻影
    • 核磁共振模型
    • 核醫學檢查體模
    • 其他產品類型
  • 按材料
    • 刺激器
    • 假器官
  • 最終用戶
    • 醫院
    • 診斷中心
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Bartec Technologies Ltd
    • Biodex Medical System Inc.
    • Carville
    • Computerized Imaging Reference Systems Inc.
    • Gold Standard Phantoms
    • Kyoto Kagaku Co. Ltd
    • Leeds Test Object Ltd
    • Modus Medical Device Inc.
    • PTW Freiburg GmbH
    • Pure Imaging Phantoms
    • QUART GmbH
    • True Phantom Solutions

第7章 市場機會與今後動向

簡介目錄
Product Code: 68529

The Medical Imaging Phantom Market is expected to register a CAGR of 5.1% during the forecast period.

Key Highlights

  • The market was affected by the COVID-19 pandemic. The decrease in imaging volumes during the pandemic affected the growth pace of the market. For instance, the COVID-19 epidemic had a severe impact on wait times for medical imaging operations across the country, according to a report from the Canadian Association of Radiologists in 2021. For CT scans, the wait time ranged from 50 to 82 days, and for MRI imaging, it was 89 days on average. That exceeded the advised 30-day wait time by 20 to 52 days. Waitlists were even longer as a result of COVID-19, affecting the market growth. However, imaging instruments were used to identify the long-term effect of diseases on patients. Recent advancements in image-guided radiation therapy are expected to improve the quality of life for patients and their families (IGRT). For instance, in September 2022, Qure.ai partnered with the University Medical Center Rotterdam to launch a laboratory for medical imaging. The initial program is estimated to run for 3 years to conduct detailed medical imaging to understand the effects of COVID-19 with the help of Chest CTs, X-rays, and brain CTs. Thus, with such partnerships, the medical imaging phantom market is expected to increase during the forecast period.
  • Factors such as the increasing burden of diseases, coupled with growing awareness and advancement in products are expected to increase the market growth. Increasing diseases such as neurological diseases which require imaging to monitor and understand the areas of the brain to check how it reacts to different stimuli are expected to increase the market growth. For instance, as per the September 2022 report of the World Health Organization (WHO), about 55 million people around the world were living with dementia, and nearly 10 million cases are reported every year. Also, as per the same source, Alzheimer's is the most common form of dementia and constitutes about 60-70% of the total cases of dementia. Similarly, according to the February 2022 update of the WHO, about 50 million people with epilepsy are living around the world, making it one of the most prevalent neurological diseases, with 80% of the population with epilepsy residing in low- and middle-income countries. Hence, the high burden of neurological disorders is expected to increase the market growth as they require medical imaging to provide specific care to patients, and the studied market is expected to grow.
  • Similarly, grants are another factor in market growth as they provide infrastructural support for the utilization of phantom imaging in drug development. For instance, in March 2022, Gold Standard Phantoms was selected for the 2022 P4 Precision Medicine Accelerator Programme. The company invested in specialized phantoms for MRI human tissue and organ imaging in living subjects under this project. By granting access to unmatched expertise, significant relationships, and new connections, this six-month program, coordinated by University College London and Capital Enterprise, establishes a novel and distinctive environment to support the growth and adoption of precision medicine SMEs. Thus, such grants utilize imaging phantoms in drug developments which increases the market growth during the forecast period. Thus, with the abovementioned factors such as the increasing burden of diseases, coupled with growing awareness and advancement in products, the medical imaging phantom market is expected to grow over the forecast period. However, the high cost of procedures and the lack of trained professionals are expected to hinder market growth.

Medical Imaging Phantom Market Trends

Nuclear Imaging Phantoms Segment is Expected to Hold a Major Market Share in the Medical Imaging Phantom Market

A nuclear imaging phantom is a specially designed system that scans or is imaged in the field of medical imaging to evaluate, analyze, and tune the performance of various imaging devices like PET/CT, etc. Factors such as increasing cancer cases coupled with initiatives by key players are expected to increase the market growth. For instance, according to data from Cancer Facts & Figures 2022, 1.9 million new cancer cases will be discovered, and there will be 609,360 cancer fatalities in the US in 2022. Globally, the use of PET imaging for research has increased as a result of the prevalence of cancer. Numerous academic research has examined the application of nuclear imaging in cancer. For instance, a study that was published in the National Library of Medicine in April 2021 found that FDG PET/CT imaging had a high negative predictive value in detecting cervical lymph node metastasis in patients with newly diagnosed, treatment-naive squamous cell carcinoma (SCC) of the oral cavity. Thus, increasing research studies are expected to increase market growth by providing insight into the applications of nuclear imaging, which is expected to increase the adoption for the treatment of various diseases. Thus, increasing the market growth in the future.

Furthermore, initiatives such as acquisitions by key market players are another factor in market growth as acquisitions help the expansion of key players either in product segments or geography, or both. For instance, in September 2021, Mirion Technologies Inc. acquired Computerized Imaging Reference Systems Inc., a provider of medical imaging and radiation therapy phantoms serving the medical industry. Such initiatives are expected to increase the availability of products in various regions and thus increase the market growth. Thus, the abovementioned factors are expected to increase the medical imaging phantom market growth.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to have a significant share in the medical imaging phantom market due to the increased funding and product installation in the region.

The increased funding in the region is expected to increase the adoption of medical imaging, which is expected to increase market growth during the forecast period. For instance, in July 2021, to improve Quebec's health and social services infrastructure, including hospitals and other care facilities, the federal government of Canada and the province of Quebec partnered to invest in 209 infrastructure projects in part by USD 188.3 million each from the Federal Minister of Infrastructure and Communities and the Minister of Health and Social Services. The funds provided hospitals with access to sophisticated medical technology. Thus, the building of new hospitals during the forecast period is expected to increase the adoption of medical imaging, which is expected to increase the demand for medical imaging phantom in the region.

In addition, product installation in healthcare facilities is another factor in market growth as it increases the wider adoption of the technology in the region. For instance, in November 2022, Perimeter Medical Imaging AI Inc. installed the Perimeter S-Series OCT system in a hospital in North Texas. Perimeter is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs. Thus, such installations are expected to increase market growth over the forecast period. Thus, the abovementioned factors such as increasing funding, and product installations are expected to increase the medical imaging phantom market growth.

Medical Imaging Phantom Market Competitor Analysis

The medical imaging phantom market is moderately competitive and consists of several major players, and some of the companies which are currently dominating the market are Carville, Computerized Imaging Reference Systems, Inc., Pure Imaging Phantoms, Biodex Medical System, Inc., Leeds Test Object Ltd., Bartec Technologies Ltd., Gold Standard Phantoms, Kyoto Kagaku Co., Ltd, Modus Medical Device Inc., and PTW Freiburg GmbH among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic Diseases
    • 4.2.2 Advancement in Products
    • 4.2.3 Growing Awareness about Diagnostic Imaging
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Procedures
    • 4.3.2 Lack of Trained Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 X Ray Phantoms
    • 5.1.2 Ultrasound Phantoms
    • 5.1.3 MRI Phantoms
    • 5.1.4 Nuclear Imaging Phantoms
    • 5.1.5 Other Product Types
  • 5.2 By Material
    • 5.2.1 Stimulating Devices
    • 5.2.2 False Organ
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bartec Technologies Ltd
    • 6.1.2 Biodex Medical System Inc.
    • 6.1.3 Carville
    • 6.1.4 Computerized Imaging Reference Systems Inc.
    • 6.1.5 Gold Standard Phantoms
    • 6.1.6 Kyoto Kagaku Co. Ltd
    • 6.1.7 Leeds Test Object Ltd
    • 6.1.8 Modus Medical Device Inc.
    • 6.1.9 PTW Freiburg GmbH
    • 6.1.10 Pure Imaging Phantoms
    • 6.1.11 QUART GmbH
    • 6.1.12 True Phantom Solutions

7 MARKET OPPORTUNITIES AND FUTURE TRENDS